Company: AZN
Filing Date: 2025-06-26
Form Type: 11-K
Source: 0001683168-25-004771
Chunk: 16

Company: ASTRAZENECA PLC
Filing Date: 2025-06-26
Form: 11-K
Chunk 16
---
 Private Equity Funds:                                                      |     |                                                                               |     |          |     |                   |
|     | DCM Private Equity Fund II LLC                                                            |     | Private Equity Fund                                                           |     | **       |     |           296,638 |
|     | Summit Partners Private Equity Fund VII                                                   |     | Private Equity Fund                                                           |     | **       |     |           508,213 |
|     |                                                                                           |     |                                                                               |     |          |     |           804,851 |
|     | Notes receivable from participants (interest rates ranging from 3.25% to 9.5%             |     |                                                                               |     |          |     |                   |
|     | and range of maturity in years 2025-2038)                                                 |     |                                                                               |     | **       |     |        46,022,222 |
|     | Total                                                                                     |     |                                                                               |     |          |     |   $ 8,626,014,092 |
|     | * Party-in-interest                                                                       |     |                                                                               |     |          |     |                   |
|     | **Cost information is not required for participant-directed investments.                  |     |                                                                               |     |          |     |                   |
|     | ***Represents the investment underlying Synthetic Guaranteed Investment Contracts ("GIC") |     |                                                                               |     |          |     |                   |

| 17 |

<div align='center'>ASTRAZENECA SAVINGS AND SECURITY PLAN

Notes to Financial Statements

December 31, 2024 and 2023

_______________

SIGNATURE</div>

Pursuant to the requirements
of the Securities and Exchange Act of 1934, the trustees (or other persons who administer the Plan) have duly caused this annual report
to be signed on its behalf by the undersigned hereunto duly authorized.

|                    | ASTRAZENECA SAVINGS AND SECURITY PLAN      |
| Date: 26 June 2025 | By: /s/ David E. White                     |
|                    | David E. White                             |
|                    | Assistant Treasurer North America, and     |
|                    | AstraZeneca Investment Committee Secretary |

| 18 |

<div align='center'>ASTRAZENECA SAVINGS AND SECURITY PLAN

Notes to Financial Statements

December 31, 2024 and 2023

_______________

INDEX TO EXHIBIT</div>

| 19 |